Loading…
MicroPort Endovascular MedTech Group announced it will spend USD 65 million to acquire the remaining 72.7% stake in Optimum Medical Device, an asset-holding firm whose core asset is UK-based Lombard Medical, a developer of aortic stents.
“The transaction will help strengthen MicroPort Endovascular's leading position in the aortic intervention medical device market and improve the innovation and R&D of aortic vascular stents.”www2.yicaiglobal.com
Summarized from public sources; check the original articles before acting on it.